Studies in animal models suggest that oxygen radicals may be important in the pathogenesis of acute pancreatitis. Because glutathione is an essential component of the defense against radical-mediated cellular injury, we investigated whether pancreatic glutathione content is influenced by inducing acute pancreatitis and whether augmenting the intracellular supply of glutathione would alter the course of pancreatitis. Caerulein, a decapeptide cholecystokinin analogue, induces acute necrotizing pancreatitis in mice when given in high doses (50 ,ag/kg per h) over a period of 6 h. The pancreatic glutathione content (total, GSH + GSSG) in mice treated with high-dose caerulein fell to 17% of normal within 4 h of beginning caerulein and recovered toward normal after discontinuing caerulein treatment. Mice treated with glutathione monoethyl ester (20 mmol/kg 1 h before caerulein, 10 mmol/kg 3 and 7 h after starting caerulein) were found to have blunted depletion of pancreatic glutathione, diminished histologic evidence ofpancreatitis (necrosis, inflammation, and vacuolization), and lower serum amylase values compared with mice treated with caerulein alone. These findings suggest that the profound depletion of pancreatic glutathione caused by hyperstimulation ofthe pancreas with caerulein is critically important in the pathogenesis of acute caerulein-induced pancreatitis. (J. Clin. Invest. 1992.
Introduction
Acute pancreatitis is a destructive process of the pancreas that can lead to severe illness and even death. Although a number of seemingly diverse causes of acute pancreatitis are recognized clinically, the events occurring at the molecular level leading to self-destruction of this organ have not been fully defined in humans or in experimental animal models (1) . Because of this incomplete understanding, rational treatments aimed at preventing pancreatitis or limiting the progression of ongoing disease are unavailable and the best current therapy relies solely on nonspecific supportive measures (2) .
To further define the cellular and molecular events leading to tissue injury in acute pancreatitis, a number ofexperimental models have been developed and exploited over the past decade. Caerulein, a decapeptide cholecystokinin analogue, causes acute pancreatitis in rats (3) and mice (4) when given in supraphysiologic doses. Evidence of tissue injury occurs rapidly in this model: pancreatic vacuolization is found within 30 min (5), progressing to marked inflammation and tissue necrosis after 6 h ofcontinuous caerulein administration (4) . Despite the well-defined histologic and biochemical progression ofpancreatitis in this experimental model as well as others, the intracellular events leading to cell injury and necrosis remain inadequately defined. Abnormal activation and intracellular release of the normally inactive precursor forms of the pancreatic digestive enzymes has been proposed as one process that may be important in the pathogenesis of acute pancreatitis (5, 6 ). Another line of evidence derived from several models of experimental pancreatitis suggests that oxygen radicals could also be important in mediating pancreatic injury (7) (8) (9) . A logical corollary to the oxygen radical theory of pancreatitis is that the endogenous antioxidant defense mechanisms of the pancreatic acinar cell serve a critically important role in preventing the onset or diminishing the progression ofpancreatitis. One essential element ofthe intracellular defense against reactive oxygen species is glutathione, the most abundant nonprotein sulfhydryl in the cell. By reacting directly with electrophilic compounds and by serving as a reductant for the elimination of hydrogen peroxide and lipid hydroperoxides, glutathione plays a vital role in the defense against reactive electrophilic metabolites and oxidant stress.
We Preparation oftissues. At various time points after the first caerulein injection, animals were anesthetized with ether and pancreatic tissue was removed for glutathione, DNA, ATP, and y-glutamyltranspeptidase (yGT)' measurements. Liver samples were obtained simultaneously for glutathione measurement and kidney samples were obtained for yGT measurement. Tissue samples for glutathione measurement were frozen immediately in liquid nitrogen and stored at -700C. Mixed arteriovenous blood was obtained after decapitation of the animals; the blood was centrifuged at 10,000 g for 10 min, and the supernatant serum was stored at -70'C until assayed for amylase activity.
Glutathione measurement. Frozen tissue samples were weighed rapidly and homogenized in 20 volumes 5% (wt/vol) sulfosalicylic acid. Allowing pancreas samples to thaw results in rapid and irreversible loss of glutathione. After centrifugation at 13,000 g for 3 min, the total glutathione content (reduced and oxidized, GSH + GSSG) and oxidized glutathione content were determined in the supernatant by HPLC analysis of the glutathione-orthophthalaldehyde adduct (11) .
Briefly, to determine total glutathione, a mixture of 100 tul supernatant, 50 Ml 0.1 M Tris, pH 8.5, 50 ,l 0.8 M NaOH, and 50 Ml 0.05 M DTT was kept on ice for a period of 30 min to allow disulfide reduction. The mixture was diluted by addition of 0.75 ml water and a 0.2-ml aliquot was derivatized by mixing with 0.2 ml orthophthalaldehyde, 5 mg/ml in 0.4 M potassium borate, pH 9.4. After 1 min, the solution was diluted further by addition of 2 ml 0.1 M sodium phosphate, pH 7.0, and a 120-Ml aliquot was analyzed by HPLC. Oxidized glutathione was measured after first eliminating the reduced glutathione by treating the neutralized SSA supernatant with 0.5 mM (final concentration) N-ethylmaleimide for 5 min followed by disulfide reduction with DTT as described above. The samples were eluted over a C18 reverse-phase column isocratically with 0.15 M sodium acetate, pH 7.00, containing 7 .5% (vol/vol) methanol. The derivative was detected fluorometrically by measuring emission at 420 nm with excitation at 340 nm. Quantitation was performed by comparing derivative peak area to known standards.
Biochemical determinations. Pancreatic DNA content was determined with a fluorescent reagent (reagent 33258; Hoechst) ( 12) . Pancreatic ATP content was determined using the firefly luciferase-luciferin assay (Los Alamos Diagnostics, Inc., Los Alamos, NM) and a Pico-Lite luminometer (Packard Instrument Co., Inc., Downers Grove, IL). Tissue yGT activity was determined as described by Swinnen (13) . Serum was analyzed for amylase activity using the Phadebas test (Pharmacia Diagnostics, Inc., Fairfield, NJ).
Histologic grading. A pancreatic fragment from each animal was fixed in 10% buffered Formalin, embedded in paraffin, and sections stained with hematoxylin and eosin. Each sample was graded blindly for the extent of necrosis, vacuolization, and inflammation as described previously (4, 14) .
Statistical analysis. Statistical significance was determined using analysis of variance and the Newman-Keuls test of multiple groups.
Results
Effect ofcaerulein treatment on pancreatic glutathione content. During the induction ofacute pancreatitis in mice by caerulein administration, the total pancreatic glutathione content (reduced + oxidized) dropped precipitously. In mice adminis-1. Abbreviation used in this paper: yGT, y-glutamyltranspeptidase. tered caerulein, 50 Ag/kg per h over 6 h, the glutathione content dropped by 43% within the 1st h and after 4 h, a nadir of 17% of normal was reached ( Fig. 1 ). Glutathione content remained at this nadir while caerulein administration continued and began to rise after its discontinuation. After a 4-d convalescence period, the pancreatic glutathione content of these animals had recovered to normal. When glutathione content was determined relative to pancreatic DNA content rather than tissue weight, the same phenomenon was observed, with the glutathione content reaching a nadir of 27% of normal at 4 h. The liver glutathione ofthese animals remained constant over the course of treatment in a range of 4 to 5 ,mol/g liver (data not shown).
Lower doses of caerulein also caused a loss of pancreatic glutathione. When a dose of 0.1 g/kg was given on the same schedule as the higher dose, pancreatic glutathione content fell to 68% of normal at 4 h (Fig. 1) . Similarly, when mice were given the midrange dose of 5 ug/kg, glutathione content fell to 30% at 4 h. As with the highest dose, the glutathione content returned towards normal afterdiscontinuing caerulein administration at these lower doses.
The intracellular redox equilibrium of glutathione usually favors the reduced form within tissues and this was found to be true in the pancreas as well. During the progression of pancreatitis in mice treated with 50Mg/kg caerulein, the fraction in the oxidized form was found to be 2.8-4.5% of the total glutathione content.
Effect ofglutathione monoethyl ester during caerulein treatment. Glutathione monoethyl ester given before and during treatment with caerulein blunted the effect ofcaerulein on pancreatic glutathione content. Although caerulein still induced a significant drop in pancreatic glutathione in these animals, the nadir of 1.09 Mmol/g was significantly higher than the nadir of 0.43 umol/g in animals treated with caerulein alone in this experiment (Fig. 2) . Histologic evidence ofpancreatic injury in caerulein-treated mice was as described previously (4) (Table I) . Glutathione monoethyl ester appeared to be less protective against the appearance of vacuoles, edema, and lobular disarray (Table I) . Biochemical evidence of pancreatitis was determined by measuring serum amylase activity. In parallel with improvement in the histologic findings, treatment with glutathione monoethyl ester significantly diminished the degree of serum amylase elevation caused by caerulein treatment (Table II) The beneficial effects of SOD, catalase, and allopurinol described in these studies constitute indirect evidence that oxygen radicals may be involved in the pathogenetic mechanisms of acute pancreatitis. More direct evidence of radical-mediated processes occurring during pancreatitis has also been reported. Nonaka et al. (23) found increased indices of pancreatic lipid peroxidation in mice fed a choline-deficient, ethionine-supplemented diet. In the caerulein model of acute pancreatitis, recent studies have described elevations in several indices of oxidant stress, such as malondialdehyde (24, 25) , conjugated dienes (24) , and chemiluminescence (26) .
This evidence for oxygen radical involvement in acute pancreatitis led us to examine elements of the endogenous cellular defense against these species. We now demonstrate that inducing pancreatitis in mice by caerulein administration causes a rapid drop in pancreatic glutathione content, a drop that precedes biochemical and histologic evidence of injury. This temporal relationship might suggest that glutathione loss is an early event leading to or potentiating pancreatic injury rather than a secondary phenomenon. Interestingly, moderate pancreatic glutathione depletion was also caused by caerulein when given at the physiologically stimulatory dose of 0.1 g/kg, a dose previously shown not to induce pancreatic injury as assessed biochemically or histologically (27). This finding further suggests that caerulein induces a loss of glutathione by a direct effect rather than as a consequence ofinjury. Despite the intracellular events leading to glutathione loss, the ability ofthe cell to maintain glutathione in a predominantly reduced state appears to remain intact.
The potentially critical role ofpancreatic glutathione depletion in the processes leading to pancreatic injury was examined by augmenting the intracellular glutathione content with intraperitoneal administration of glutathione monoethyl ester. Whereas extracellular glutathione is unable to traverse the cell membrane intact (15, 16, 28) , the glycine-carboxyl ethyl ester ofglutathione has been found to enter readily into the cytosolic space of a number oftissues, whereupon it undergoes hydrolysis to yield free glutathione (29) . The precise mechanisms involved in transmembrane transport and subsequent ester cleavage are unknown. Nonetheless, this compound has proved to be an effective glutathione prodrug in a variety ofexperimental models. The pancreas appears to take up and hydrolyze glutathione monoethyl ester (28, 30) and in this study supraphysiologic levels ofpancreatic glutathione were achieved 1 h after the first dose (Fig. 2) .
The protection against histologic and biochemical evidence of pancreatitis afforded by concomitant glutathione monoethyl ester treatment supports a major role for glutathione in protecting against this mechanism of injury. It is unlikely that glutathione depletion alone is adequate for the production of pancreatitis, because pancreatitis has not been reported in studies of glutathione depletion, including one recent study of prolonged glutathione depletion in mice (28) . Just as glutathione augmentation is found to be protective against caerulein-induced injury, glutathione depletion most likely exerts a permissive effect: when the intracellular glutathione content is depleted to a certain threshold, the yet-undefined mechanisms involved in caerulein-induced injury might then proceed unchecked. Although these mechanisms of injury are yet to be fully defined, the studies suggesting that generation of oxygen radicals is an important component of the events leading to pancreatitis is consistent with the present hypothesis that glutathione depletion exerts a permissive effect, which could be the generation of hydrogen peroxide and lipid hydroperoxides.
The events leading to the caerulein-induced glutathione depletion are not established. Any net loss of glutathione would result from either inadequate synthesis or increased catabolism, the latter known to occur rapidly even in normal pancreas (15, 16, 28) . If caerulein induced a complete block in glutathione synthesis, the glutathione requirement from turnover should be met by the provision of glutathione monoethyl ester (28) . In these studies this was not the case, because pancreatic glutathione levels fell in ester-treated animals, despite starting with supraphysiologic levels.
In addition to three precursor amino acids, glutathione synthesis also requires an adequate supply of ATP. The depletion of pancreatic ATP during caerulein treatment, although not profound, could exert an inhibitory effect on the overall rate of glutathione synthesis as the intracellular ATP content is near the Km of the two enzymes in the glutathione-synthetic pathway (31) . Nonetheless, implicating ATP depletion as a cause of the glutathione loss is difficult, as the ATP levels remain normal 1 h after the first caerulein injection, a time at which the glutathione content has dropped by 43%. Thus, the observed ATP depletion later in the course of caerulein treatment most likely represents a secondary effect that may contribute to diminished GSH synthesis after depletion but does not cause depletion per se.
Rapid consumption or catabolism of glutathione are alternative explanations for the caerulein-induced pancreatic glutathione depletion. Irreversible consumption of glutathione can occur in an environment of ongoing lipid peroxidation (32). Reactive carbonyl lipid peroxidation products such as 4-hydroxynonenal react with glutathione to form stable conjugates; one proposed mechanism of peroxidative tissue injury is, indeed, the reaction of such species with essential intracellular components when the supply of glutathione has been depleted (32) . If the caerulein-induced loss of pancreatic glutathione is occurring by this mechanism, it would suggest that the cause of oxidant stress is not glutathione depletion, but that glutathione depletion is a result of the ongoing generation of reactive species. This is consistent with other models of lipid peroxidation where short-term glutathione depletion alone, without a source of oxidant stress, is not associated with peroxidative tissue injury.
The possibility that increased glutathione catabolism explains the caerulein-induced loss ofglutathione cannot be eliminated. Little is known of normal intracellular breakdown of glutathione, if it occurs at all. The enzyme yGT is a facile glutathione peptidase and is, in its usual orientation, exposed to the extracellular milieu of epithelial cells and thus unable to degrade the high intracellular glutathione content that most tissues maintain. The possibility that the usual orientation of this enzyme is altered by caerulein administration to allow intracellular glutathione breakdown was tested by inhibiting the activity of this enzyme. A 70% inhibition of pancreatic yGT activity did not blunt the fall in glutathione, suggesting that this enzyme is not responsible for the caerulein-induced loss ofglutathione. In fact, inhibition of yGT appeared to potentiate glutathione loss, a finding consistent with the idea that yGT is important in transporting glutathione precursor amino acids across the cell membrane into the cytosolic compartment (15) . ered resistant to the actions of normal intracellular peptidases, an inappropriate intracellular release of pancreatic digestive enzymes could play a yet unrecognized role in glutathione loss. This possibility will be the subject of further studies.
